Deciphering spatial genomic heterogeneity at a single cell resolution in multiple myeloma
Source : https://www.researchsquare.com/article/rs-146899/v1
Osteolytic lesions (OL) characterize symptomatic multiple myeloma. The mechanisms of how malignant plasma cells (PC) cause OL in one region while others show no signs of bone destruction despite subtotal...
Alterations of NK Cell Phenotype in the Disease Course of Multiple Myeloma
Explore millions of resources from scholarly journals, books, newspapers, videos and more, on the ProQuest Platform.
Reporter/Multiple Myeloma/car-t-cell-therapies-bispecific-antibodies-and-antibody-conjugates
CAR T-Cell Therapies, Bispecific Antibodies, and Antibody Conjugates
Source : https://expertperspectives.com/Conference
Aggressive B-Cell Non-Hodgkin Lymphoma: Molecular Profiling and Post-Treatment Surveillance
An update on B-cell maturation antigen-targeted therapies in Multiple Myeloma
Source : https://doi.org/10.1080/14712598.2021.1872540
ABSTRACT Introduction: B-cell maturation antigen (BCMA) targeted therapy (BCMA-TT) has emerged as a promising treatment for Multiple Myeloma (MM). the three most common treatment modalities for targeting BCMA are antibody-drug...
Imaging Techniques for Response Assessment and Follow-Up
Source : https://link.springer.com/chapter/10.1007/978-3-030-63662-3_5
Leo Rasche Anke Heidemeier Stefan Delorme Niels Weinhold A recent study in newly diagnosed multiple myeloma (MM) patients revealed that high-risk tumor clones can be restricted to focal lesions (FLs)...